Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
P53 Expression in benign Breast Disease Development: A Systematic Review.
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2485-2491. doi: 10.31557/APJCP.2020.21.9.2485.
Asian Pac J Cancer Prev. 2020.
PMID: 32986343
Free PMC article.
P53 expression was more frequent among tissues with fibrocystic disease (22.5%) and fibroadenoma (22.5%). CONCLUSION: When compared with all breast tissues types, benign breast disease corresponds to 34.39% of p53 expression. ...In addition, more studies considering ethnic …
P53 expression was more frequent among tissues with fibrocystic disease (22.5%) and fibroadenoma (22.5%). CONCLUSION: When compared w …
[The HRT follow-up consultation. What to do in case of breast tumour (clinical or radiological) and microcalcifications. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Mathelin C, Molière S.
Mathelin C, et al.
Gynecol Obstet Fertil Senol. 2021 May;49(5):485-492. doi: 10.1016/j.gofs.2021.03.026. Epub 2021 Mar 20.
Gynecol Obstet Fertil Senol. 2021.
PMID: 33757919
French.
Clinical examination, mammography, and ultrasonography suggest a benign solid tumour. The management of these benign breast lesions (fibroadenoma) is not different in women taking an HRT and there is no contraindication to continue the HRT. 4: Clinical examination, imaging …
Clinical examination, mammography, and ultrasonography suggest a benign solid tumour. The management of these benign breast lesions (fibr …
Item in Clipboard
Cite
Cite